Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Drugs for Treatment of Crohn's Disease in IBD Using Glucocorticoids01:21

Drugs for Treatment of Crohn's Disease in IBD Using Glucocorticoids

Glucocorticoids, a class of anti-inflammatory drugs, are pivotal in treating moderate to severe Crohn's disease by inducing remission. They exhibit their anti-inflammatory action by inhibiting the production of inflammatory cytokines such as tumor necrosis factor (TNF)-α, interleukin (IL)-1, and chemokines like IL-8. In addition, they reduce the expression of inflammatory cell adhesion molecules and inhibit gene transcription of nitric oxide synthase, phospholipase A2, cyclooxygenase-2 (COX-2),...
Rheumatic Heart Disease I: Introduction01:23

Rheumatic Heart Disease I: Introduction

Rheumatic heart disease or RHD is a chronic condition that results from rheumatic fever, causing permanent damage to the heart valves.Etiology and Risk FactorsIt primarily arises from rheumatic fever, an inflammatory disease that can develop after untreated or inadequately treated group A streptococcal (GAS) pharyngitis. Streptococcus spreads through direct contact with oral or respiratory secretions. While the bacteria are the causative agents, factors like malnutrition, overcrowding, poor...
T Cell Types and Functions01:24

T Cell Types and Functions

When T cells with CD4 markers are activated, they give rise to two types of effector cells: helper T cells and regulatory T cells. Meanwhile, T cells with CD8 markers differentiate into effector cytotoxic T cells. The differentiation of CD4 T cells into helper T cell subsets, such as Th1, Th2, and Th17 cells, is dependent on the antigen type, antigen-presenting cell, and regulatory cytokines.
Th1 cells stimulate dendritic cells to express necessary co-stimulatory molecules on their surfaces for...
The JAK-STAT Signaling Pathway01:20

The JAK-STAT Signaling Pathway

Several cytokine receptors have tightly bound Janus kinase or JAK proteins attached at their cytosolic tail. Small signaling molecules such as cytokines, growth hormones, or prolactins bind to the cytokine receptors and initiate their dimerization. The dimerization brings the cytosolic JAKs together that trans-phosphorylate and activates each other. The activated JAKs now phosphorylate cytosolic tails of the cytokine receptors, which serve as binding sites for adaptor proteins such as  SH2...
Genome-wide Association Studies-GWAS01:11

Genome-wide Association Studies-GWAS

Genome-wide association studies or GWAS are used to identify whether common SNPs are associated with certain diseases. Suppose specific SNPs are more frequently observed in individuals with a particular disease than those without the disease. In that case, those SNPs are said to be associated with the disease. Chi-square analysis is performed to check the probability of the allele likely to be associated with the disease.
GWAS does not require the identification of the target gene involved in...
Rheumatic Heart Disease II: Clinical Manifestations and Diagnostic Studies01:22

Rheumatic Heart Disease II: Clinical Manifestations and Diagnostic Studies

The key clinical manifestations of Rheumatic heart disease (RHD) include several distinct cardiac symptoms.Carditis, a hallmark of acute rheumatic fever, involves inflammation of the heart's endocardium, myocardium, and pericardium. Chronic RHD often results from recurrent episodes of carditis. Its symptoms include the following:Murmurs are caused by valvular damage, especially to the mitral and aortic valves. Mitral stenosis or regurgitation is common, with characteristic heart murmurs...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Acquired hypothalamic dysfunction in childhood: 'what do patients need?' - an Endo-ERN survey.

Endocrine connections·2023
Same author

Leukocyte Telomere Length in Children With Congenital Adrenal Hyperplasia.

The Journal of clinical endocrinology and metabolism·2022
Same author

Adherence and long-term outcomes of therapy in paediatric patients in Greece using the easypod™ electromechanical device for growth hormone treatment: The phase IV multicentre easypod™ connect observational study (ECOS).

Growth hormone & IGF research : official journal of the Growth Hormone Research Society and the International IGF Research Society·2020
Same author

Misfolding Ectodomain Mutations of the Lutropin Receptor Increase Efficacy of Hormone Stimulation.

Molecular endocrinology (Baltimore, Md.)·2015
Same author

Novel causes of generalized glucocorticoid resistance.

Hormone and metabolic research = Hormon- und Stoffwechselforschung = Hormones et metabolisme·2007
Same author

Basic and clinical implications of glucocorticoid action--focus on development. National Institutes of Health, Bethesda, Maryland, USA. June 17-18, 2003. Introduction and abstracts.

Hormone and metabolic research = Hormon- und Stoffwechselforschung = Hormones et metabolisme·2003

Related Experiment Video

Updated: May 28, 2026

An Adoptive Transfer Model of Rheumatoid Arthritis in Mice
07:37

An Adoptive Transfer Model of Rheumatoid Arthritis in Mice

Published on: June 6, 2025

Glucocorticoid receptor: implications for rheumatic diseases.

T Kino1, E Charmandari, G P Chrousos

  • 1Eunice Kennedy Shriver National Institute of Child Health and Human Development, National Institutes of Health, Bethesda, MD 20892, USA. kinot@mail.nih.gov

Clinical and Experimental Rheumatology
|October 25, 2011
PubMed
Summary
This summary is machine-generated.

The glucocorticoid receptor (GR) has two main forms, GRα and GRβ, influencing immune responses and potentially rheumatic diseases. Understanding GR regulation offers therapeutic timing strategies for autoimmune disorders.

More Related Videos

An Immunohistopathologic Study to Profile the Folate Receptor Beta Macrophage and Vascular Immune Microenvironment in Giant Cell Arteritis
06:35

An Immunohistopathologic Study to Profile the Folate Receptor Beta Macrophage and Vascular Immune Microenvironment in Giant Cell Arteritis

Published on: February 8, 2019

Related Experiment Videos

Last Updated: May 28, 2026

An Adoptive Transfer Model of Rheumatoid Arthritis in Mice
07:37

An Adoptive Transfer Model of Rheumatoid Arthritis in Mice

Published on: June 6, 2025

An Immunohistopathologic Study to Profile the Folate Receptor Beta Macrophage and Vascular Immune Microenvironment in Giant Cell Arteritis
06:35

An Immunohistopathologic Study to Profile the Folate Receptor Beta Macrophage and Vascular Immune Microenvironment in Giant Cell Arteritis

Published on: February 8, 2019

Area of Science:

  • Molecular biology
  • Endocrinology
  • Immunology

Background:

  • The glucocorticoid receptor (GR) is a key mediator of glucocorticoid effects.
  • The human GR gene yields two isoforms, GRα and GRβ, through alternative splicing.
  • GRα binds glucocorticoids and mediates classical actions, while GRβ inhibits GRα activity.

Purpose of the Study:

  • To elucidate the structure, function, and isoforms of the glucocorticoid receptor.
  • To explore the role of GR in immune system regulation.
  • To investigate the potential involvement of GRβ in rheumatic diseases and therapeutic implications of GR circadian regulation.

Main Methods:

  • Analysis of the human GR gene structure and alternative splicing.
  • Characterization of GRα and GRβ isoforms and their functions.
  • Review of genomic and non-genomic GR actions, including immune system regulation.

Main Results:

  • GRα is the primary glucocorticoid-binding receptor, mediating transcriptional regulation.
  • GRβ acts as a dominant negative regulator of GRα.
  • GR exhibits both genomic and rapid non-genomic effects, impacting the immune system.

Conclusions:

  • GR isoforms play critical roles in immune regulation.
  • GRβ may be implicated in the pathogenesis of rheumatic diseases.
  • Circadian regulation of GR activity presents therapeutic opportunities for autoimmune inflammatory disorders.